Successful Radiation Therapy for Midgut Carcinoid Tumors
Author Information
Author(s): Kölby L, Bernhardt P, Johanson V, Schmitt A, Ahlman H, Forssell-Aronsson E, Mäcke H, Nilsson O
Primary Institution: Göteborg University, Sahlgrenska University Hospital
Hypothesis
Can somatostatin receptor-mediated radiation therapy effectively treat human midgut carcinoid tumors in a xenograft model?
Conclusion
The study found that receptor-mediated radiation therapy can lead to complete remission in most treated tumors.
Supporting Evidence
- 22 out of 23 animals treated with therapeutic doses showed complete remission.
- The absorbed dose to tumors was significantly higher with therapeutic amounts compared to diagnostic amounts.
- Apoptosis was rapidly induced in tumors treated with the therapeutic dose.
Takeaway
This study shows that a special type of radiation therapy can make most tumors go away in mice with a specific kind of cancer.
Methodology
The study used nude mice with human midgut carcinoid tumors and treated them with varying doses of [177Lu-DOTA0-Tyr3]-octreotate to assess tumor response.
Limitations
The study was conducted in a mouse model, which may not fully replicate human responses.
Participant Demographics
Nude mice were used as the model organism.
Statistical Information
P-Value
0.00032
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website